U.K. court deems Seroquel XR patent invalid; Bayer CEO: Our biggest goal is organic growth;

 @FiercePharma: Sandoz morphine mislabeling prompts urgent notice. News | Follow @FiercePharma

> AstraZeneca ($AZN) said the formulation patent protecting its Seroquel XR has been deemed invalid by the High Court in the U.K. Accord Healthcare, Intas Pharmaceuticals, Hexal AG and Sandoz, Teva U.K. and Teva Pharmaceutical Industries ($TEVA) were challenging the patent. News

> Bayer CEO Marijn Dekkers said his company is under no pressure to pursue major takeovers or divestments to overhaul its diversified structure. He added that his company's top goal is organic growth. Report

> Unigene Laboratories said the U.S. Supreme Court denied Apotex's Petition for a Writ of Certiorari. The decision upholds the validity of Unigene's U.S. patent on Fortical that was previously confirmed by the District Court and the Court of Appeals for the Federal Circuit. Unigene release

> Sigma Pharmaceuticals has returned to profitability after gaining market share. The next 12 to 18 months will see the company rebuilding core capabilities and establishing options for growth. News

> Guido Magni is joining Swiss firm Versant Ventures to help expand its biotechnology footprint. Item

> An Abbott Laboratories ($ABT) infant formula product failed to reach China national safety standards and tested worst among a selection of 6 powders sold there, according to a research report released by Hong Kong-based research house CER Research. Release

Biotech News

 @FierceBiotech: Whooping cough bug evades vaccine in Australia. Story | Follow @FierceBiotech

 @JohnCFierce: Culling data from heart drug studies, researchers find that aspirin is linked with a reduction in risk of cancer death. Article | Follow @JohnCFierce

 @RyanMFierce: Addex Therapeutics came out today with positive Phase IIa data for Parkinson's drug supported by MJF Foundation. Release | Follow @RyanMFierce

@MarkHFierce: Embryonic stem-cell research is under fire at U-M, The Detroit Free Press reports. Perplexing. Piece | Follow @MarkHFierce

> New drug for rare leukemia wins FDA panel vote with limited data. News

Manufacturing News

> GSK to invest more than £500 million in new manufacturing in U.K. Story

> Nobilus Poland plant gets import ban after FDA warning. News

> Sandoz finds outside suppliers for drugs in shortage. Article

Vaccines News

> DNA melanoma vaccine shows hope in early studies. Item

> iBio shares jump with flu shot clinical trial. More

> TB vaccine in South African trials; blueprint will drive development. Article

CRO News

> Novartis chief touts new effort to offer streamlined, consumer-friendly trials. Story

> inVentiv grabs Kforce's clinical research staff biz for $50M. News

> CRO lobby steps up social media outreach on YouTube. Article

And Finally... Should your company pay you to volunteer abroad? Eli Lilly ($LLY) does. Story